Background: The proliferation of inhaler devices has resulted in a confusing number of choices for clinicians who are selecting a delivery device for aerosol therapy. There are advantages and ...

The global aerosol delivery devices market was valued at $31,463.9 million in 2019, and is projected to reach $46,728.7 million by 2027, registering a CAGR of 4.9% from 2020 to 2027. Rise in ...

Proair HFA (albuterol sulfate) Inhalation Aerosol is supplied as a pressurized ... deterioration of asthma and requires reevaluation of treatment. There is a pregnancy exposure registry that ...

This report also discusses clinical and theoretical indications for GSH inhalation, potential concerns with this treatment, its presumed mechanisms of action, optimal doses to be administered and ...

Acetylcysteine 100mg/mL, 200mg/mL; soln for inhalation; preservative-free. See literature for administration of aerosol ... as much as 300mL during a single treatment period; recommended dose ...

Using aerosol inhalation as a method of drug delivery has the potential to treat a range of diseases and conditions more efficiently and effectively than current methods. The size, phase, composition, ...

Aztreonam for inhalation solution is approved by the FDA to improve respiratory symptoms in patients with cystic fibrosis with P. aeruginosa infection 6. Analysing issues in the treatment of ...